Nima Razzaghi-Asl (N Razzaghi-Asl)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Brain Metastases

Top Venues

Molecular diversity

Journal of biomolecular structure & dynamics

Turkish journal of chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

S Shahabipour, A N Shamkhali, Nima Razzaghi-Asl
Cytotoxic monastrol derivatives as adjective inhibitors of drug-resistant Eg5: a molecular dynamics perspective. Journal of biomolecular structure & dynamics (2024)
Elaheh Mohammadnejadi, Nima Razzaghi-Asl
In silico target specific design of potential quinazoline-based anti-NSCLC agents. Journal of biomolecular structure & dynamics (2023)
Behnam Mohammadi-Ghalehbin, Jafar Abbasi Shiran, Nastaran Gholizadeh, Nima Razzaghi-Asl
Synthesis, antileishmanial activity and molecular modeling of new 1-aryl/alkyl-3-benzoyl/cyclopropanoyl thiourea derivatives. Molecular diversity (2022)
Saba Rezvani, Ahmad Ebadi, Nima Razzaghi-Asl
In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations. Journal of biomolecular structure & dynamics (2021)
Mohsen Sagha, Fatemeh Mousaei, Mahtab Salahi, Nima Razzaghi-Asl
Synthesis of new 2-aminothiazolyl/benzothiazolyl-based 3,4-dihydropyrimidinones and evaluation of their effects on adenocarcinoma gastric cell migration. Molecular diversity (2021)
Zahra Hosseinzadeh, Nima Razzaghi-Asl, Ali Ramazani, Hamideh Aghahosseini, Ali Ramazani
Synthesis, cytotoxic assessment, and molecular docking studies of 2,6-diaryl-substituted pyridine and 3,4- dihydropyrimidine-2(1H)-one scaffolds. Turkish journal of chemistry 44 (1) (2020)
Nima Razzaghi-Asl, Saghi Sepehri, Ahmad Ebadi, Pari Karami, Negin Nejatkhah, Mohammad Johari-Ahar
Insights into the current status of privileged N-heterocycles as antileishmanial agents. Molecular diversity 24 (2) (2019)